Australia - englanti - Department of Health (Therapeutic Goods Administration)

brauer professional pty ltd - cardiospermum halicacabum -

Australia - englanti - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - candesartan cilexetil, quantity: 32 mg; hydrochlorothiazide, quantity: 25 mg - tablet - excipient ingredients: hyprolose; magnesium stearate; glyceryl monostearate; carmellose calcium; lactose monohydrate; maize starch; iron oxide yellow; iron oxide red - the treatment of hypertension. treatment should not be initiated with these fixed dose combinations.

Australia - englanti - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - hydrochlorothiazide, quantity: 12.5 mg; candesartan cilexetil, quantity: 32 mg - tablet - excipient ingredients: carmellose calcium; hyprolose; maize starch; glyceryl monostearate; lactose monohydrate; magnesium stearate; iron oxide yellow - the treatment of hypertension. treatment should not be initiated with these fixed dose combinations.

Australia - englanti - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - candesartan cilexetil, quantity: 8 mg - tablet, uncoated - excipient ingredients: magnesium stearate; carmellose calcium; glyceryl monostearate; hyprolose; iron oxide red; lactose monohydrate; maize starch - treatment of hypertension. treatment of patients with heart failure and impaired left ventricular systolic function, left ventricular ejection fraction less than or equal to 40 percent, as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated.

Australia - englanti - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - candesartan cilexetil, quantity: 4 mg - tablet, uncoated - excipient ingredients: hyprolose; glyceryl monostearate; magnesium stearate; carmellose calcium; lactose monohydrate; maize starch - treatment of hypertension. treatment of patients with heart failure and impaired left ventricular systolic function, left ventricular ejection fraction less than or equal to 40 percent, as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated.

Australia - englanti - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - candesartan cilexetil, quantity: 32 mg - tablet, uncoated - excipient ingredients: hyprolose; iron oxide red; glyceryl monostearate; magnesium stearate; maize starch; carmellose calcium; lactose monohydrate - treatment of hypertension. treatment of patients with heart failure and impaired left ventricular systolic function, left ventricular ejection fraction less than or equal to 40 percent, as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated.

Australia - englanti - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - candesartan cilexetil, quantity: 16 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; magnesium stearate; glyceryl monostearate; maize starch; hyprolose; iron oxide red; carmellose calcium - treatment of hypertension. treatment of patients with heart failure and impaired left ventricular systolic function, left ventricular ejection fraction less than or equal to 40 percent, as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated.

Australia - englanti - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - hydrochlorothiazide, quantity: 12.5 mg; candesartan cilexetil, quantity: 16 mg - tablet, uncoated - excipient ingredients: hyprolose; iron oxide yellow; maize starch; iron oxide red; glyceryl monostearate; carmellose calcium; lactose monohydrate; magnesium stearate - the treatment of hypertension. treatment should not be initiated with this fixed dose combination.

Australia - englanti - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - candesartan cilexetil -

Australia - englanti - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - candesartan cilexetil; hydrochlorothiazide -